These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8726804)

  • 21. The circadian timing system: a coordinator of life processes: chronobiological investigations. Implications for the rhythmic delivery of cancer therapeutics.
    Lévi FA
    IEEE Eng Med Biol Mag; 2008; 27(1):17-9. PubMed ID: 18270045
    [No Abstract]   [Full Text] [Related]  

  • 22. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
    Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolving concepts in the systemic drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic rhythms in hematology.
    Haus E
    Pathol Biol (Paris); 1996 Sep; 44(7):618-30. PubMed ID: 8977919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.
    Lévi F; Filipski E; Iurisci I; Li XM; Innominato P
    Cold Spring Harb Symp Quant Biol; 2007; 72():465-75. PubMed ID: 18419306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronometaanalysis: circasemiseptan (3.5-day) pattern in mitotic activity of murine sarcoma after treatment with cyclophosphamide.
    Focan C; Cornélissen G; Halberg F
    In Vivo; 1995; 9(4):401-6. PubMed ID: 8555441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronobiology, drug-delivery, and chronotherapeutics.
    Lemmer B
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):825-7. PubMed ID: 17825947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer chronotherapeutics: experimental, theoretical, and clinical aspects.
    Ortiz-Tudela E; Mteyrek A; Ballesta A; Innominato PF; Lévi F
    Handb Exp Pharmacol; 2013; (217):261-88. PubMed ID: 23604483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronobiology in the endocrine system.
    Haus E
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):985-1014. PubMed ID: 17804113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dynamic circadian system patients under chimiotherapy].
    Beau J; Iurisci I; Beau T; Lévi F
    Pathol Biol (Paris); 2007; 55(3-4):171-5. PubMed ID: 17412521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seasonal modulation of the 8-and 24-hour rhythms of ondansetron tolerance in mice.
    Khedhaier A; Ben-Attia M; Gadacha W; Sani M; Reinberg A; Boughattas NA
    Chronobiol Int; 2007; 24(6):1199-212. PubMed ID: 18075807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hardware and software for (and results from) chronobiologic approaches to cancer treatment and prevention.
    Halberg F
    Chronobiologia; 1986; 13(4):355-8. PubMed ID: 3816409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current concepts for chronochemotherapy of cancer.
    Laerum OD; Smaaland R; Abrahamsen JF
    J Infus Chemother; 1995; 5(3 Suppl 1):159-70. PubMed ID: 8528978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer chronotherapy: principles, applications, and perspectives.
    Mormont MC; Levi F
    Cancer; 2003 Jan; 97(1):155-69. PubMed ID: 12491517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronochemotherapy for cancer].
    Akazawa S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1191-202. PubMed ID: 9279336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Euchronism, allochronism, and dyschronism: is internal desynchronization of human circadian rhythms a sign of illness?
    Reinberg AE; Ashkenazi I; Smolensky MH
    Chronobiol Int; 2007; 24(4):553-88. PubMed ID: 17701673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of circadian rhythms on the kinetics of drugs in humans.
    Baraldo M
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):175-92. PubMed ID: 18248311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.